Immunotherapy: Pushing the Frontier of Cancer Medicine

Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment. As of July 31, 2023, at least 23 different cancer immunotherapeutics have been approved by the FDA.

Immunotherapy: Pushing the Frontier of Cancer Medicine

What is Immunotherapy?

Advancing Cancer Science and Medicine

American Association for Cancer Research (AACR)

Supporting Cancer Patients and Survivors

Merck's Second Tissue-Agnostic Approval for Keytruda Reignites TMB Cutoff Debate

Immunotherapy: Pushing the Frontier of Cancer Medicine

Chapter 4 - Immunotherapy: The Future of Medicine

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players - Drug Discovery and Development

Diseases, Free Full-Text